| Analysis | Metabolite Name | Measured Value | Units | Type |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 9598173.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 11436068.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 12477795.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 12906784.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 13137009.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 13171745.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 13187909.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 13310283.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 13386889.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 13451035.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 13599079.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 13760023.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 13861228.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 14534318.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 14574922.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 14645210.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 14693662.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 15033829.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 15184387.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 15693179.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 15847291.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 15993001.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 16212820.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 16432932.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 16493339.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 16549922.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 17289284.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 17534174.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 17647882.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 17866248.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 18426184.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 18706838.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 19110548.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 19688752.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 19819002.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 19839588.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 20147632.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 20639364.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 20881820.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 21530832.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 21613168.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 21969290.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 22216768.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 22662316.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 23038452.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 23396160.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 23691528.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 23896294.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 24737214.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 25046558.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 25097268.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 25286240.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 25772852.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 26861948.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 28187832.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 29158664.00 | raw area counts | Control |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 30201648.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 31102046.00 | raw area counts | Crohn disease |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 31343846.00 | raw area counts | Ulcerative Colitis |
| Reversed phase NEGATIVE ION MODE | 5-oxoproline | 32744746.00 | raw area counts | Control |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|